Glutamine synthetase mRNA releases sRNA from its 3´UTRto regulate carbon/nitrogen metabolic balance in Enterobacteriaceae

  1. Masatoshi Miyakoshi  Is a corresponding author
  2. Teppei Morita
  3. Asaki Kobayashi
  4. Anna Berger
  5. Hiroki Takahashi
  6. Yasuhiro Gotoh
  7. Tetsuya Hayashi
  8. Kan Tanaka
  1. University of Tsukuba, Japan
  2. Keio University, Japan
  3. Chiba University, Japan
  4. Kyushu University, Japan
  5. Tokyo Institute of Technology, Japan

Abstract

Glutamine synthetase (GS) is the key enzyme of nitrogen assimilation induced under nitrogen limiting conditions. The carbon skeleton of glutamate and glutamine, 2-oxoglutarate, is supplied from the TCA cycle, but how this metabolic flow is controlled in response to nitrogen availability remains unknown. We show that the expression of the E1o component of 2-oxoglutarate dehydrogenase, SucA, is repressed under nitrogen limitation in Salmonella enterica and E coli. The repression is exerted at the post-transcriptional level by an Hfq-dependent sRNA GlnZ generated from the 3´UTR of the GS-encoding glnA mRNA. Enterobacterial GlnZ variants contain a conserved seed sequence and primarily regulate sucA through base-pairing far upstream of the translation initiation region. During growth on glutamine as the nitrogen source, the glnA 3´UTR deletion mutants expressed SucA at higher levels than the S. enterica and E. coli wild-type strains, respectively. In E. coli, the transcriptional regulator Nac also participates in the repression of sucA. Lastly, this study clarifies that the release of GlnZ from the glnA mRNA by RNase E is essential for the post-transcriptional regulation of sucA. Thus the mRNA coordinates the two independent functions to balance the supply and demand of the fundamental metabolites.

Data availability

The RNA-seq data have been deposited in DDBJ DRA under accession number DRA012682.

The following data sets were generated

Article and author information

Author details

  1. Masatoshi Miyakoshi

    Department of Infection Biology, University of Tsukuba, Tsukuba, Japan
    For correspondence
    mmiyakoshi@md.tsukuba.ac.jp
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4901-2809
  2. Teppei Morita

    Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan
    Competing interests
    The authors declare that no competing interests exist.
  3. Asaki Kobayashi

    Transborder Medical Research Center, University of Tsukuba, Tsukuba, Japan
    Competing interests
    The authors declare that no competing interests exist.
  4. Anna Berger

    International Joint Degree Master's Program in Agro-Biomedical Science in Food and Health, University of Tsukuba, Tsukuba, Japan
    Competing interests
    The authors declare that no competing interests exist.
  5. Hiroki Takahashi

    Medical Mycology Research Center, Chiba University, Chiba, Japan
    Competing interests
    The authors declare that no competing interests exist.
  6. Yasuhiro Gotoh

    Department of Bacteriology, Kyushu University, Fukuoka, Japan
    Competing interests
    The authors declare that no competing interests exist.
  7. Tetsuya Hayashi

    Department of Bacteriology, Kyushu University, Fukuoka, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6366-7177
  8. Kan Tanaka

    Laboratory for Chemistry and Life Science, Tokyo Institute of Technology, Yokohama, Japan
    Competing interests
    The authors declare that no competing interests exist.

Funding

Japan Society for the Promotion of Science (JP19H03464)

  • Masatoshi Miyakoshi

Japan Society for the Promotion of Science (JP19KK0406)

  • Masatoshi Miyakoshi

Japan Society for the Promotion of Science (JP21K19063)

  • Masatoshi Miyakoshi

Japan Society for the Promotion of Science (JP22H02236)

  • Kan Tanaka

Japan Society for the Promotion of Science (JP16H06279)

  • Hiroki Takahashi
  • Tetsuya Hayashi

Waksman Foundation of Japan

  • Masatoshi Miyakoshi

Takeda Medical Research Foundation

  • Masatoshi Miyakoshi

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2022, Miyakoshi et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,653
    views
  • 240
    downloads
  • 10
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Masatoshi Miyakoshi
  2. Teppei Morita
  3. Asaki Kobayashi
  4. Anna Berger
  5. Hiroki Takahashi
  6. Yasuhiro Gotoh
  7. Tetsuya Hayashi
  8. Kan Tanaka
(2022)
Glutamine synthetase mRNA releases sRNA from its 3´UTRto regulate carbon/nitrogen metabolic balance in Enterobacteriaceae
eLife 11:e82411.
https://doi.org/10.7554/eLife.82411

Share this article

https://doi.org/10.7554/eLife.82411

Further reading

    1. Microbiology and Infectious Disease
    Ziyu Wen, Pingchao Li ... Caijun Sun
    Research Article

    The persistence of latent viral reservoirs remains the major obstacle to eradicating human immunodeficiency virus (HIV). We herein found that ICP34.5 can act as an antagonistic factor for the reactivation of HIV latency by herpes simplex virus type I (HSV-1), and thus recombinant HSV-1 with ICP34.5 deletion could more effectively reactivate HIV latency than its wild-type counterpart. Mechanistically, HSV-ΔICP34.5 promoted the phosphorylation of HSF1 by decreasing the recruitment of protein phosphatase 1 (PP1α), thus effectively binding to the HIV LTR to reactivate the latent reservoirs. In addition, HSV-ΔICP34.5 enhanced the phosphorylation of IKKα/β through the degradation of IκBα, leading to p65 accumulation in the nucleus to elicit NF-κB pathway-dependent reactivation of HIV latency. Then, we constructed the recombinant HSV-ΔICP34.5 expressing simian immunodeficiency virus (SIV) env, gag, or the fusion antigen sPD1-SIVgag as a therapeutic vaccine, aiming to achieve a functional cure by simultaneously reactivating viral latency and eliciting antigen-specific immune responses. Results showed that these constructs effectively elicited SIV-specific immune responses, reactivated SIV latency, and delayed viral rebound after the interruption of antiretroviral therapy (ART) in chronically SIV-infected rhesus macaques. Collectively, these findings provide insights into the rational design of HSV-vectored therapeutic strategies for pursuing an HIV functional cure.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Mai Nguyen, Elda Bauda ... Cecile Morlot
    Research Article

    Teichoic acids (TA) are linear phospho-saccharidic polymers and important constituents of the cell envelope of Gram-positive bacteria, either bound to the peptidoglycan as wall teichoic acids (WTA) or to the membrane as lipoteichoic acids (LTA). The composition of TA varies greatly but the presence of both WTA and LTA is highly conserved, hinting at an underlying fundamental function that is distinct from their specific roles in diverse organisms. We report the observation of a periplasmic space in Streptococcus pneumoniae by cryo-electron microscopy of vitreous sections. The thickness and appearance of this region change upon deletion of genes involved in the attachment of TA, supporting their role in the maintenance of a periplasmic space in Gram-positive bacteria as a possible universal function. Consequences of these mutations were further examined by super-resolved microscopy, following metabolic labeling and fluorophore coupling by click chemistry. This novel labeling method also enabled in-gel analysis of cell fractions. With this approach, we were able to titrate the actual amount of TA per cell and to determine the ratio of WTA to LTA. In addition, we followed the change of TA length during growth phases, and discovered that a mutant devoid of LTA accumulates the membrane-bound polymerized TA precursor.